Provided by Tiger Trade Technology Pte. Ltd.

iShares Neuroscience and Healthcare ETF

38.84
-0.1201-0.31%
Volume:4K
Turnover:157.03K
Market Cap:7.77M
PE:- -
High:38.84
Open:38.66
Low:38.65
Close:38.96
52wk High:43.01
52wk Low:24.96
Shares:200.00K
Float Shares:200.00K
Volume Ratio:8.24
T/O Rate:2.03%
Dividend:0.32
Dividend Rate:0.82%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Scholar Rock Holding Corp - Apitegromab Bla Under FDA Review with Sept 30, 2026 Pdufa Date

THOMSON REUTERS
·
Jul 20

Alkermes Plc : Stifel Raises Target Price to $63 from $45

THOMSON REUTERS
·
Jul 20

Analysts Offer Insights on Healthcare Companies: Harmony Biosciences Holdings (HRMY) and Alkermes (ALKS)

TIPRANKS
·
Jul 20

Praxis Precision Medicines (PRAX) Could Be 49% Undervalued As Patch Deal Expands Ulixacaltamide Reach

Simply Wall St.
·
Jul 20

Wuxi Ranks Among China's Top Ten Happiest Cities Once Again

Deep News
·
Jul 18

Scholar Rock Reports New Employee Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Jul 18

17-Year Research Effort Solves Medical Power Challenge: Wang Zhonglin's Team Achieves Breakthrough in Self-Powering Human Heart Pacemakers, with Potential for Brain-Computer Interfaces

Deep News
·
Jul 17

Scholar Rock to Report Q2 2026 Financial Results, Host Conference Call

Reuters
·
Jul 16

First Prescription for Implantable Brain-Computer Interface Issued in Shanghai, Pioneering Surgery Offers New Hope for Spinal Cord Injury Patients

Deep News
·
Jul 15

Alkermes Schedules Second-quarter Results Call and Webcast

Reuters
·
Jul 15

Alkermes to Report Second Quarter Financial Results on July 28, 2026

THOMSON REUTERS
·
Jul 15

BrainAurora-B Stock Surges Over 26% Following 14-Department Policy Document Highlighting Brain-Computer Interface Technology

Stock News
·
Jul 14

Policy Boost for Assistive Devices and Brain-Computer Interface Sector as 14 Ministries Issue Joint Action Plan

Stock News
·
Jul 14

Dianthus Therapeutics EVP, CFO and CBO Ryan Savitz Disposes of Common Shares Worth $3.06 Million

Reuters
·
Jul 14

Analysts Conflicted on These Healthcare Names: Alkermes (ALKS), TransMedics Group (TMDX) and Praxis Precision Medicines (PRAX)

TIPRANKS
·
Jul 14

Alkermes Plc : TD Cowen Raises Target Price to $57 from $50

THOMSON REUTERS
·
Jul 13

Analysts Are Bullish on Top Healthcare Stocks: Praxis Precision Medicines (PRAX), Sino Biopharmaceutical (SBMFF)

TIPRANKS
·
Jul 13

Alkermes Price Target Announced at $60.00/share by JP Morgan

Dow Jones
·
Jul 13

Alkermes Says Alixorexton Sustains Wakefulness Gains in Nine-month Narcolepsy Extension Study Interim Analysis

Reuters
·
Jul 13

Alkermes - Alixorexton Generally Well Tolerated at All Doses Tested

THOMSON REUTERS
·
Jul 13